Laboratory Aspects of Infections

  • J. D. Williams
  • A. M. Geddes

Part of the Chemotherapy book series (CT, volume 2)

Table of contents

  1. Front Matter
    Pages i-xiv
  2. J. C. Sherris
    Pages 1-6
  3. R. Blowers, D. F. J. Brown
    Pages 7-12
  4. H. Neussel
    Pages 33-40
  5. S. H. Zinner, R. B. Provonchee, K. S. Elias
    Pages 55-59
  6. Kunitomo Watanabe, Keiu Ninomiya, Izumi Mochizuki, Toshio Miwa, Hiromu Imamura, Shunro Kobata et al.
    Pages 71-76
  7. M. Taufer, J. Zangger
    Pages 77-80
  8. Toshio Miwa, Izumi Mochizuki, Kunitomo Watanabe, Shunro Kobata, Hiromu Imamura, Keiu Ninomiya et al.
    Pages 89-93
  9. P. J. McDonald, W. A. Craig, C. M. Kunin
    Pages 95-102
  10. D. W. Kerry, J. M. T. Hamilton-Miller, W. Brumfitt
    Pages 103-106
  11. R. A. A. Watson, E. J. Shaw, C. R. W. Edwards
    Pages 107-110
  12. Anna-Stina Malmborg
    Pages 115-124
  13. M. J. Harber, A. W. Asscher
    Pages 125-131
  14. D. S. Reeves, H. A. Holt
    Pages 133-141
  15. J. D. Jarvis, T. W. C. Leung
    Pages 143-146
  16. D. C. Shanson, C. Hince, J. V. Daniels
    Pages 147-153
  17. Enno Freerksen, Magdalena Rosenfeld
    Pages 169-175
  18. G. N. Rolinson
    Pages 183-189
  19. K. R. Comber, C. D. Osborne, R. Sutherland
    Pages 191-196
  20. Lawrence R. Freedman, Georges Demierre
    Pages 197-204
  21. G. E. Mawer
    Pages 235-240
  22. J. G. Bartlett, A. B. Onderdonk, T. Louie, S. L. Gorbach
    Pages 249-258
  23. Ch. Krüger, R. Commichau, W. Henkel
    Pages 267-272
  24. W. Ritzerfeld, R. Koschmieder, W. Drees
    Pages 281-287
  25. P. A. Hunter, G. N. Rolinson, D. A. Witting
    Pages 289-293
  26. M. Hatala, J. Morávek, O. Schück, V. Prát, M. Liška, J. Spousta
    Pages 295-301
  27. Ch. Krüger, H. Freiesleben, K. Sack, R. Commichau
    Pages 303-309
  28. R. Commichau, H. Freiesleben, K. Sack, Ch. Krüger, W. Henkel
    Pages 317-322
  29. Smith Shadomy, Christopher Utz
    Pages 335-344

About this book


The International Society of Chemotherapy meets every two years to review progress in chemotherapy of infections and of malignant disease. Each meeting gets larger to encompass the extension of chemotherapy into new areas. In some instances, expansion has been rapid, for example in cephalosporins, pen­ icillins and combination chemotherapy of cancer - in others slow, as in the field of parasitology. New problems of resistance and untoward effects arise; reduction of host toxicity without loss of antitumour activity by new substances occupies wide attention. The improved results with cancer chemotherapy, es­ pecially in leukaemias, are leading to a greater prevalence of severe infection in patients so treated, pharmacokinetics of drugs in normal and diseased subjects is receiving increasing attention along with related problems of bioavailability and interactions between drugs. Meanwhile the attack on some of the major bacterial infections, such as gonorrhoea and tubercu­ losis, which were among the first infections to feel the impact of chemotherapy, still continue to be major world problems and are now under attack with new agents and new methods. From this wide field and the 1,000 papers read at the Congress we have produced Proceedings which reflect the variety and vigour of research in this important field of medicine. It was not possible to include all of the papers presented at the Congress but we have attempted to include most aspects of cur­ rent progress in chemotherapy.


cancer chemotherapy kinetics pharmacokinetics research resistance toxicity

Editors and affiliations

  • J. D. Williams
    • 1
  • A. M. Geddes
    • 2
  1. 1.The London Hospital Medical CollegeLondonUK
  2. 2.East Birmingham HospitalBirminghamUK

Bibliographic information